SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-151836
Filing Date
2024-05-31
Accepted
2024-05-31 16:25:31
Documents
13
Period of Report
2024-05-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d809302d8k.htm   iXBRL 8-K 32092
  Complete submission text file 0001193125-24-151836.txt   151475

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gh-20240524.xsd EX-101.SCH 2854
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE gh-20240524_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gh-20240524_pre.xml EX-101.PRE 10817
16 EXTRACTED XBRL INSTANCE DOCUMENT d809302d8k_htm.xml XML 3496
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

IRS No.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 241010127
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)